Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eslicarbazepine (Stedesa) can be used for adjunctive therapy for adults with partial-onset seizures.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 11,000 | |||
10 mg | 在庫あり | ¥ 18,500 | |||
25 mg | 在庫あり | ¥ 35,500 | |||
50 mg | 在庫あり | ¥ 55,000 | |||
100 mg | 在庫あり | ¥ 85,500 | |||
200 mg | 在庫あり | ¥ 126,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 12,000 |
説明 | Eslicarbazepine (Stedesa) can be used for adjunctive therapy for adults with partial-onset seizures. |
別名 | Pazzul, EC 810-248-9, BIA 2-194, Stedesa, Erelib |
分子量 | 254.28 |
分子式 | C15H14N2O2 |
CAS No. | 104746-04-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 12 mg/mL (47.19 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eslicarbazepine 104746-04-5 Membrane transporter/Ion channel Neuroscience Sodium Channel Beta-Secretase Pazzul Inhibitor EC 810-248-9 inhibit BIA 2-194 Stedesa Erelib inhibitor